Stoke Therapeutics, Inc. STOK
26.54 USD +0.47 (+1.80%)
At closeNov 9, 2026, 4:13 AM EST
26.16 -0.38 -1.43%
Pre-market · Nov 9, 4:13 AM ET
25.96 Day range 26.72
21.81 52-week range 40.22
- YTD
- -16.38%
- 1 year
- +16.10%
News
benzinga.com Stoke Therapeutics Q3 2026 Earnings Call Transcript Stoke Therapeutics (NASDAQ:STOK) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com Stoke Therapeutics Q3 EPS $(1.08) Misses $(0.93) Estimate, Sales $11.255M Beat $8.185M Estimate Stoke Therapeutics (NASDAQ:STOK) reported quarterly losses of $(1.08) per share which missed the analyst consensus estimate of $(0.93) by 16.13 percent. This is a 66.15 percent decrease over losses…
benzinga.com Stoke Therapeutics Presents Data For STK-002 Supporting Disease-Modifying Potential In Autosomal Dominant Optic Atrophy At AAO 2026 Annual Meeting –ADOA is the most common inherited optic nerve disorder and is primarily caused by variants in the OPA1 gene that result in insufficient levels of OPA1 protein, leading to progressive and…